Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Thumb IndustriesGTBIF +1.26%84 EV-to-EBITDA is 3.84 as of Sep. 02, 2026, which is 60% below its 10-year median of 9.65. GuruFocus rates GTBIF with a GF Score™ of 84/100 and a GF Value™ of $8.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 727 Drug Manufacturers companies, Green Thumb Industries ranks better than 91.33% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Green Thumb Industries's enterprise value is $1,948 Mil.
Green Thumb Industries's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $507 Mil. Therefore, Green Thumb Industries's EV-to-EBITDA for today is 3.84.
The historical rank and industry rank for Green Thumb Industries's EV-to-EBITDA or its related term are showing as below:
GTBIF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -634.27 Med: 9.65 Max: 1056.02
Current: 3.84
During the past 13 years, the highest EV-to-EBITDA of Green Thumb Industries was 1056.02. The lowest was -634.27. And the median was 9.65.
GTBIF's EV-to-EBITDA is ranked better than 91.33% of 727
companies
in the Drug Manufacturers industry
Industry Median: 13.35
vs GTBIF: 3.84
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Green Thumb Industries (OTCPK:GTBIF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Green Thumb Industries's PE Ratio (TTM) for today is calculated as:
Green Thumb Industries's share price for today is $7.635.
Green Thumb Industries's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Thumb Industries EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Green Thumb Industries's EV-to-EBITDA falls into.
Green Thumb Industries's current Enterprise Value is $1,948 Mil.
Green Thumb Industries's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $507 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Thumb Industries (GTBIF) has a EV-to-EBITDA of 3.84 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Green Thumb Industries. This is 60% below median its historical median of 9.65. According to the industry distribution chart, Green Thumb Industries ranks #63 out of 727 companies in the Drug Manufacturers industry, placing it in the top 8.7%.
Is Green Thumb Industries' EV-to-EBITDA too high?
Green Thumb Industries' current EV-to-EBITDA of 3.84 is 60% below median its 10-year median of 9.65. The Drug Manufacturers industry median EV-to-EBITDA is 13.35. Green Thumb Industries' value of 3.84 is 71.2% below this industry median. Based on the distribution chart, Green Thumb Industries ranks #63 out of 727 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Green Thumb Industries has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Green Thumb Industries' EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Green Thumb Industries ranks #63 out of 727 companies for EV-to-EBITDA. This places Green Thumb Industries in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.35. Green Thumb Industries' value of 3.84 is 71.2% below this benchmark. While the company's 10-year median is 9.65 vs. the industry median of 13.35, Green Thumb Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.35, based on 727 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Thumb Industries's current EV-to-EBITDA of 3.84 is 71.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Green Thumb Industries. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Thumb Industries's current EV-to-EBITDA is 3.84, which is 60% below median its own 10-year median of 9.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Thumb Industries stock overvalued right now?
Based on GuruFocus' analysis, Green Thumb Industries (GTBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.68, compared to a current price of $7.64 — trading 12% below its estimated fair value. The current EV-to-EBITDA is 3.84, which is 60% below median its 10-year median of 9.65 and 71.2% below the Drug Manufacturers industry median of 13.35. Green Thumb Industries' overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Green Thumb Industries (GTBIF), the current EV-to-EBITDA is 3.84 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Thumb Industries (GTBIF) Overvalued in 2026?
Based on GuruFocus' analysis, Green Thumb Industries stock appears to be undervalued.
The current stock price of $7.64 is trading 12% below its estimated GF Value™ of $8.68.
GuruFocus considers Green Thumb Industries to be Modestly Undervalued.
Key valuation signals for GTBIF:
EV-to-EBITDA: 3.84 (60% below median its 10-year median of 9.65)
GF Value™: $8.68 vs. price of $7.64 (12% below fair value)
Industry Position: 71.2% below the Drug Manufacturers median (#63 of 727)
No single metric tells the full story. See the GTBIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
84GF Score
Get the complete analysis for GTBIF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GTBIF has been successfully added to your 
